ScholarLens Back to search
2015•Journal of Nuclear MedicineOpen access

Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough?

Françoise Kraeber‐Bodéré, Jacques Patrick Barbet, Jean‐François Chatal

Open full text 25 citations

Abstract

Radioimmunotherapy is a targeted molecular therapy that bears on radiobiologic and immunologic processes, without cross-resistance with other anticancer cytotoxic drugs. Since the first reports in the literature at the beginning of the 1980s, radioimmunotherapy techniques have significantly

Open-access reader

About this research paper

What this paper is about

Radioimmunotherapy is a targeted molecular therapy that bears on radiobiologic and immunologic processes, without cross-resistance with other anticancer cytotoxic drugs. Since the first reports in the literature at the beginning of the 1980s, radioimmunotherapy techniques have significantly

Why it matters

OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Radioimmunotherapy is a targeted molecular therapy that bears on radiobiologic and immunologic processes, without cross-resistance with other anticancer cytotoxic drugs. Since the first reports in the literature at the beginning of the 1980s, radioimmunotherapy techniques have significantly

Key concepts: Radioimmunotherapy, Medicine, Medical physics, Oncology, Cancer research, Internal medicine, Immunology, Antibody

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough? — Research Paper | ScholarLens